In a groundbreaking advancement destined to reshape our understanding of tuberculosis (TB), researchers at the Massachusetts Institute of Technology (MIT) have unveiled a novel chemical approach to label specific glycans within the formidable cell wall of Mycobacterium tuberculosis. This technique, which targets the unique sulfur-containing sugars exclusive to a few bacterial species, provides an unprecedented window into the complex glycobiology of the pathogen responsible for one of the deadliest infectious diseases worldwide.
Tuberculosis claims over a million lives each year and infects approximately ten million people globally. The pathogen’s success hinges, in part, on its resilient cell envelope—a dense matrix replete with complex sugar molecules known as glycans. These glycans not only serve as structural components but also modulate host immune recognition, contributing to the bacteria’s ability to evade immune clearance. Despite their significance, the intricate roles and behaviors of these glycans within the infection process have remained elusive, primarily due to the historic lack of effective molecular labeling tools capable of visualizing glycans inside host cells.
Addressing this critical gap, the MIT team has pioneered a chemical strategy that exploits the reactivity of thioether groups within specific glycans. Their method focuses on a glycan named mannose-capped lipoarabinomannan (ManLAM), which harbors the rare sugar motif MTX featuring a thioether—characterized by a sulfur atom bound between two carbons. By designing an oxaziridine-based small molecule that selectively reacts with these thioether groups, the researchers attached fluorescent probes directly to ManLAM within live mycobacterial cells, effectively illuminating the glycan’s spatial distribution in the bacterial cell wall.
This innovative labeling approach overcomes the traditional challenges associated with targeting glycans. Unlike nucleic acids or proteins, glycans lack unique sequences or chemical handles and cannot be genetically encoded with fluorescent tags. The approach leverages the distinct chemical signature of the sulfur-containing MTX sugar, thereby achieving unprecedented selectivity. When applied to Mycobacterium tuberculosis, oxaziridine labeling produced a clear fluorescent signal localized on the outer layer of the cell wall, while related species lacking MTX, such as Mycobacterium smegmatis, yielded no detectable labeling. This specificity underscores the power of the chemical tool in discriminating pathogen-associated glycans.
Beyond mapping glycan location, the MIT team also tracked the fate of labeled ManLAM during host infection. By labeling bacteria prior to infecting macrophages—immune cells that engulf pathogens—they observed that ManLAM remains firmly attached to the bacterial cell surface throughout at least the first 72 hours of infection. This finding counters previous hypotheses suggesting that ManLAM is shed into the host milieu, instead indicating a stable incorporation within the cell envelope during early infection. Such insights illuminate the mechanisms by which M. tuberculosis avoids immune detection and sustain pathogenicity.
The ability to visualize ManLAM in live bacterial cells holds tremendous promise for TB diagnostics. Current diagnostic methods, including chest X-rays and molecular assays, are highly accurate but often inaccessible in low-resource settings where TB burden is greatest. Traditional sputum culture, a mainstay in many such regions, is time-consuming and has limitations, particularly in pediatric populations who struggle to produce adequate sputum samples. The MIT researchers envision their chemical sensor as the basis for novel diagnostics that could detect ManLAM rapidly and sensitively, even from non-invasive samples such as urine, potentially transforming TB detection on a global scale.
Intriguingly, ongoing work aims to extend the labeling technique to monitor how ManLAM and the broader cell wall architecture respond to antibiotic treatment and immune activation. This might reveal how TB bacteria remodel their protective glycan barriers under stress, or how immune cells interact with cell surface glycans during infection. Such dynamic glycan ‘tracking’ could provide new therapeutic insights and guide the development of drugs that target glycan biosynthesis or modification pathways critical for bacterial survival.
The foundation of this chemical approach lies in previous developments of oxaziridine reagents that label methionine residues in proteins due to their sulfur sensitivity. Repurposing this chemistry to target a glycan’s thioether sugar moiety represents a creative fusion of synthetic chemistry and glycobiology. It highlights how tailored small molecules, informed by subtle biochemical distinctions, can unlock previously invisible aspects of microbial pathogenesis.
Importantly, this technique is not only a powerful research tool but could also fill a critical void in clinical diagnostics. Existing antibody-based ManLAM detection methods show sensitivity primarily in patients with advanced disease or co-infections, such as HIV, limiting their utility for early detection. A small-molecule probe’s ability to detect trace amounts of ManLAM may enable the development of rapid point-of-care tests with enhanced sensitivity and broader applicability. This could be especially vital for diagnosing latent or early-stage infections, where timely intervention is crucial to curbing transmission.
The collaborative effort brought together MIT chemists, graduate students, and postdoctoral researchers, showcasing multidisciplinary expertise in chemistry, biology, and infectious disease. Senior author Laura Kiessling emphasized the urgency of creating simple, rapid diagnostic tests to overcome the limitations of current TB screening methods, while lead author Stephanie Smelyansky underlined the novelty and impact of their selective glycan labeling strategy.
As the tuberculosis epidemic continues to pose a staggering global health challenge, innovations like this chemical labeling method illuminate new frontiers in understanding bacterial biology and combating infectious diseases. By revealing the subtle molecular choreography of pathogen-host interactions, such research paves the way for diagnostics and therapeutics that are both innovative and urgently needed. With further refinement and clinical translation, the oxaziridine-based glycan sensor may become an indispensable tool in the global fight against TB.
—
Subject of Research: Labeling and visualization of mycobacterial glycans in Mycobacterium tuberculosis using selective chemical probes targeting thioether-containing sugars.
Article Title: Exploiting thioether reactivity to label mycobacterial glycans
News Publication Date: 9-May-2025
Web References: http://dx.doi.org/10.1073/pnas.2422185122
Image Credits: MIT
Keywords: Tuberculosis, Mycobacterium tuberculosis, glycans, ManLAM, oxaziridine, chemical labeling, infectious diseases, glycan visualization, diagnostics, bacterial cell wall, sulfur-containing sugars, microbial pathogenesis
